Loading clinical trials...
Loading clinical trials...
Peritoneal carcinomatosis (PC) results from the metastasis of a primary cancer of the peritoneum (e.g., appendiceal, ovarian, uterine, colorectal, and gastric cancers) that then disseminates throughou...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
OncoNano Medicine, Inc.
NCT07001748 · Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, and more
NCT07282834 · Peritoneal (Metastatic) Cancer, Peritoneal Carcinomatosis, and more
NCT06511037 · Gastrointestinal Cancer, Peritoneal Carcinomatosis
NCT06929013 · Peritoneal Carcinomatosis, Peritoneal Metastases From Colorectal Cancer
NCT04107077 · Gastric Cancer, Peritoneal Carcinomatosis
Wake Forest Baptist Health
Winston-Salem, North Carolina
The Ohio State University Wexner Medical Center / James Cancer Hospital
Columbus, Ohio
Perelman School of Medicine, University of Pennsylvania
Philadelphia, Pennsylvania
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions